Chief Healthcare Executive August 1, 2024
Financial distress, value-based care, and digital healthcare services are some of the forces driving deals.
Healthcare mergers and acquisitions (M&A) were expected to make a comeback this year and so far that’s mostly on track.
In the first half of this year, global healthcare and life sciences sell-side deals, especially asset sales and mergers on Datasite, which facilitates about 14,000 new global deals annually, increased 6% compared to the same time last year.
Buy side deals, or asset purchases, on Datasite were up even more at 24% in the first six months of this year compared to last year. Since this activity represents deals at their inception rather than publicly announced, it provides a good indication of what’s to come...